{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:03:18Z","timestamp":1789833798418,"version":"4.0.1"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.micpath.2026.108823","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:03:06Z","timestamp":1788760986000},"page":"108823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Harnessing bacterial biology and components for next-generation vaccine development"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6960-8557","authenticated-orcid":false,"given":"Azadeh","family":"Zahmatkesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Esmaeilnejad-Ahranjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108823_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.53730\/ijhs.v8nS1.15436","article-title":"The impact of vaccinations on disease prevention: a comprehensive analysis of their role in enhancing global public health and reducing morbidity and mortality rates","volume":"8","author":"Alanazi","year":"2024","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/vaccines10091385","article-title":"Vaccines against emerging and neglected infectious diseases: an overview","volume":"10","author":"Vuitika","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2026.108823_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107302","article-title":"Optimization and scale-up of Clostridium perfringens type D culture and epsilon-toxin production: effects of stirring, glucose and pH adjustment","volume":"234","author":"Esmaeilnejad-Ahranjani","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.micpath.2026.108823_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2026.108286","article-title":"Vaccine development for porcine epidemic diarrhea virus and porcine Deltacoronavirus: updated progress, challenges, and future perspectives","volume":"212","author":"Tran","year":"2026","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108823_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging concepts and technologies in vaccine development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122331","article-title":"Vaccine development: current trends and technologies","volume":"336","author":"Poria","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/vaccines12010049","article-title":"Outer membrane vesicles from Acinetobacter baumannii: biogenesis, functions, and vaccine application","volume":"12","author":"Weng","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2026.108823_bib8","article-title":"Bacterial outer membrane vesicles in potentiating cancer vaccines: progress and prospects","author":"Zhang","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.micpath.2026.108823_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2026.109070","article-title":"Design and techno-economic assessment of an industrial-scale polyvalent clostridial vaccine production process","volume":"278","author":"Esmaeilnejad-Ahranjani","year":"2026","journal-title":"Toxicon"},{"key":"10.1016\/j.micpath.2026.108823_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13205-026-04914-9","article-title":"Bioreactor technologies for bacterial-based vaccine manufacturing and industrial scale-up: insights and future prospects","volume":"16","author":"Esmaeilnejad-Ahranjani","year":"2026","journal-title":"3 Biotech"},{"key":"10.1016\/j.micpath.2026.108823_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12985-023-02183-z","article-title":"The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection","volume":"20","author":"Faghihkhorasani","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2026.108823_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106440","article-title":"Recent advances in various bio-applications of bacteria-derived outer membrane vesicles","volume":"185","author":"Sadeghi","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108823_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105082","article-title":"Typhi derived vaccines and a proposal for outer membrane vesicles (OMVs) as potential vaccine for typhoid fever","volume":"158","author":"Haque","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108823_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/acsinfecdis.2c00559","article-title":"Development in the concept of bacterial polysaccharide repeating unit-based antibacterial conjugate vaccines","volume":"9","author":"Rohokale","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12934-024-02418-w","article-title":"Recombinant multiepitope proteins expressed in Escherichia coli cells and their potential for immunodiagnosis","volume":"23","author":"Gon\u00e7alves","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.micpath.2026.108823_bib16","series-title":"Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges","first-page":"197","article-title":"The role of fermentation in BCG manufacture: challenges and ways forward","author":"Walker","year":"2023"},{"key":"10.1016\/j.micpath.2026.108823_bib17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/vaccines10101578","article-title":"Outer membrane vesicles: an emerging vaccine platform","volume":"10","author":"Kashyap","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2026.108823_bib18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/microorganisms14040790","article-title":"From classical bacterins to recombinant vaccines: critical aspects of the immune response in ruminants","volume":"14","author":"Loria","year":"2026","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108823_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/toxins15090563","article-title":"Recent developments in vaccine design: from live vaccines to recombinant toxin vaccines","volume":"15","author":"Gupta","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.micpath.2026.108823_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-1605(98)00048-8","article-title":"Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes","volume":"41","author":"Pouwels","year":"1998","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib21","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2026.108823_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2020.08.008","article-title":"New horizons in adjuvants for vaccine development","volume":"65","author":"Reed","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.coi.2006.09.001","article-title":"Novel vaccines and adjuvants for allergen-specific immunotherapy","volume":"18","author":"Crameri","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2013.00282","article-title":"Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications","volume":"4","author":"Van Braeckel-Budimir","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107312","article-title":"The role and mechanisms of Helicobacter pylori outer membrane vesicles in the pathogenesis of extra-gastrointestinal diseases","volume":"200","author":"Liu","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108823_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108823_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib28","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants--in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ni712","article-title":"Toll-like receptors control activation of adaptive immune responses","volume":"2","author":"Schnare","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0105-2896.2004.00144.x","article-title":"Modulating vaccine responses with dendritic cells and toll-like receptors","volume":"199","author":"Pulendran","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2026.108823_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08830185.2018.1506780","article-title":"Evolution and species-specific conservation of toll-like receptors in terrestrial vertebrates","volume":"37","author":"Bagheri","year":"2018","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib32","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib34","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current concepts of antigen cross-presentation","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2026.108823_bib36","first-page":"406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl 3","key":"10.1016\/j.micpath.2026.108823_bib38","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.micpath.2026.108823_bib41","article-title":"Potential strategies for bacterial infection control: outer membrane vesicle based bacterial vaccines","author":"Li","year":"2026","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.micpath.2026.108823_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011141","article-title":"Oral pathobiont-derived outer membrane vesicles in the oral-gut axis","volume":"25","author":"Catalan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib43","article-title":"Trained immunity in the mucosal diseases","volume":"14","author":"Yu","year":"2022","journal-title":"WIREs Mech Dis"},{"key":"10.1016\/j.micpath.2026.108823_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-022-00485-x","article-title":"Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies","volume":"7","author":"Hameed","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.micpath.2026.108823_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13578-024-01207-7","article-title":"Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.micpath.2026.108823_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/vaccines14050440","article-title":"Bacterial membrane vesicles as versatile platforms for systemic and mucosal vaccines","volume":"14","author":"Park","year":"2026","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2026.108823_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11033-024-10146-y","article-title":"Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation","volume":"52","author":"Afzal","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.micpath.2026.108823_bib48","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","article-title":"A guide to adaptive immune memory","volume":"24","author":"Lam","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12860","article-title":"T follicular helper cells in germinal center B cell selection and lymphomagenesis","volume":"296","author":"Mintz","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2026.108823_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2026.108823_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108823_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102190","article-title":"Trained immunity: implications for vaccination","volume":"77","author":"Geckin","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100524","article-title":"Optimization of toxins and bacteria inactivation process in industrial-scale production of Clostridium perfringens bacterin-toxoid vaccine","volume":"8","author":"Esmaeilnejad-Ahranjani","year":"2025","journal-title":"Microbe"},{"key":"10.1016\/j.micpath.2026.108823_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107707","article-title":"Cu-doped Fe3O4 nanoparticles for efficient detoxification of epsilon toxin: toward substituting magnetically recyclable detoxifying agent for formaldehyde","volume":"242","author":"Esmaeilnejad-Ahranjani","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.micpath.2026.108823_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2025.108365","article-title":"Detoxification techniques for bacterial toxins: a pathway to effective toxoid vaccines","volume":"260","author":"Esmaeilnejad-Ahranjani","year":"2025","journal-title":"Toxicon"},{"key":"10.1016\/j.micpath.2026.108823_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1359-6446(01)02139-0","article-title":"Bacterial toxins as tools for mucosal vaccination","volume":"7","author":"Mrsny","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.micpath.2026.108823_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0167-5699(99)01523-6","article-title":"Structure and mucosal adjuvancy of cholera and Escherichia coli heat-labile enterotoxins","volume":"20","author":"Rappuoli","year":"1999","journal-title":"immunol today"},{"key":"10.1016\/j.micpath.2026.108823_bib59","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/infdis\/173.6.1428","article-title":"Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches","volume":"173","author":"Nakagawa","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib60","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.4049\/jimmunol.161.11.5952","article-title":"Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1\/Th2 help for virus-specific immune responses in reproductive tissues","volume":"161","author":"Imaoka","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib61","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0264-410X(01)00292-4","article-title":"Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization","volume":"20","author":"Glueck","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib62","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/IAI.66.9.4340-4346.1998","article-title":"Immunization against natural Helicobacter pylori infection in nonhuman primates","volume":"66","author":"Dubois","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib63","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults","volume":"116","author":"Michetti","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2026.108823_bib64","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/IAI.67.8.4276-4279.1999","article-title":"Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization","volume":"67","author":"Barackman","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib65","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/pro.5560061220","article-title":"Crystal structure of a non-toxic mutant of heat-labile enterotoxin, which is a potent mucosal adjuvant","volume":"6","author":"van den Akker","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib66","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0264-410X(97)00255-7","article-title":"LT(R192G), a non-toxic mutant of the heatlabile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella ssp","volume":"16","author":"Chong","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-2478(00)00257-1","article-title":"Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen","volume":"74","author":"Kanellos","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2026.108823_bib68","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/IAI.69.3.1605-1612.2001","article-title":"Intranasal immunization with SAG1 and non-toxic mutant heat-labile enterotoxins protect mice against Toxoplasma gondii","volume":"69","author":"Bonenfant","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib69","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1128\/IAI.67.9.4400-4406.1999","article-title":"Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants","volume":"67","author":"Douce","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib70","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.0.CO;2-W","article-title":"Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin","volume":"28","author":"Lee","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/iai.64.1.55-60.1996","article-title":"Vaccination with genetically modified shigalike toxin IIe prevents edema disease in swine","volume":"64","author":"Bosworth","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib72","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1016\/j.vaccine.2004.03.034","article-title":"Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity","volume":"22","author":"Ohmura-Hoshino","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib73","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2026.108823_bib74","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/323342","article-title":"Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody","volume":"184","author":"Kamboj","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib75","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1016\/j.vaccine.2017.08.056","article-title":"Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults","volume":"35","author":"van der Heiden","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib76","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/iai.63.6.2100-2108.1995","article-title":"A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K\/129G, is an effective mucosal adjuvant for intranasally delivered proteins","volume":"63","author":"Roberts","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib77","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/IAI.67.2.602-607.1999","article-title":"Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway","volume":"67","author":"Carbonetti","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib78","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.4049\/jimmunol.162.7.4157","article-title":"Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope","volume":"162","author":"Fayolle","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/iai.59.1.45-50.1991","article-title":"Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine","volume":"59","author":"Cryz","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0925-4439(92)90057-T","article-title":"Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553","volume":"1138","author":"Killeen","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.micpath.2026.108823_bib81","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0264-410X(98)00380-6","article-title":"Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses","volume":"17","author":"Mrsny","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/1074-7613(95)90050-0","article-title":"Lipopolysaccharide interferes with the induction of peripheral T cell death","volume":"2","author":"Vella","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2026.108823_bib83","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.122.4.1421","article-title":"Synergy between T cell-replacing factor and bacterial lipopolysaccharides (LPS) in the primary antibody response in vitro: a model for lipopolysaccharide adjuvant action","volume":"122","author":"Jacobs","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib84","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/IAI.01150-12","article-title":"Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria","volume":"81","author":"Chilton","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib85","first-page":"1","article-title":"Beneficial modification of the endotoxin molecule","volume":"3","author":"Ribi","year":"1984","journal-title":"J. Biol. Response Modif."},{"key":"10.1016\/j.micpath.2026.108823_bib86","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1099\/00221287-136-2-319","article-title":"Chemical, immunobiological and antigenic characterizations of lipopolysaccharides from Bacteroides gingivalis strains","volume":"136","author":"Fujiwara","year":"1990","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib87","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/jb.177.8.2098-2106.1995","article-title":"Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis","volume":"177","author":"Kumada","year":"1995","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108823_bib88","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1462-5822.2005.00672.x","article-title":"Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition","volume":"8","author":"Reife","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib89","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108823_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/IAI.00937-10","article-title":"The lipid A phosphate position determines differential host toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria","volume":"79","author":"Coats","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib91","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1462-5822.2006.00849.x","article-title":"Hierarchical gene expression profiles of HUVEC stimulated by different lipid A structures obtained from Porphyromonas gingivalis and Escherichia coli","volume":"9","author":"Chen","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.577823","article-title":"MPL adjuvant contains competitive antagonists of human TLR4","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib93","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib94","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrmicro1620","article-title":"Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences","volume":"5","author":"Royet","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib95","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1096\/fj.09-151001","article-title":"Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals","volume":"24","author":"Volz","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.micpath.2026.108823_bib96","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0264-410X(02)00547-9","article-title":"Adjuvant activity of peptidoglycan monomer and its metabolic products","volume":"21","author":"Halassy","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib97","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/iai.22.3.842-851.1978","article-title":"Extractability of cell wall polysaccharide from lactobacilli and streptococci by autoclaving and by dilue acid","volume":"22","author":"Campbell","year":"1978","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/mi.2009.131","article-title":"Neonatal mucosal immunization with a non-living, nongenetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection","volume":"3","author":"Ramirez","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1263586","article-title":"Bacterium-like particles derived from probiotics: progress, challenges and prospects","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib100","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/IAI.00077-11","article-title":"Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways","volume":"79","author":"Rae","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib101","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/ci500734k","article-title":"Understanding the structure-function relationship of lysozyme resistance in staphylococcus aureus by peptidoglycan O-acetylation using molecular docking, dynamics, and lysis assay","volume":"55","author":"Pushkaran","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.micpath.2026.108823_bib102","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00253-022-11795-4","article-title":"Peptidoglycan-based immunomodulation","volume":"106","author":"Sun","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108823_bib103","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5713\/ajas.2012.12033","article-title":"Differential expression of Th1-and Th2-Type cytokines in peripheral blood mononuclear cells of Murrah buffalo (Bubalus bubalis) on TLR2 Induction by B. Subtilis Peptidoglycan","volume":"25","author":"Shah","year":"2012","journal-title":"Asian-Australas. J. Anim. Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib104","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/157340711796817913","article-title":"Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy","volume":"7","author":"Ogawa","year":"2011","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.micpath.2026.108823_bib105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1348-0421.2012.12006.x","article-title":"Peptidoglycan-induced T helper 2 immune response in mice involves interleukin-10 secretion from Langerhans cells","volume":"57","author":"Matsui","year":"2013","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib106","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.intimp.2008.01.017","article-title":"Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oilbased adjuvants and peptidoglycan monomer","volume":"8","author":"Habjanec","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2026.108823_bib107","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/S0264-410X(02)00336-5","article-title":"Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice","volume":"20","author":"Halassy","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib108","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1016\/j.vaccine.2016.08.010","article-title":"Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model","volume":"34","author":"Holbrook","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12896-015-0195-z","article-title":"An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin","volume":"15","author":"Song","year":"2015","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.micpath.2026.108823_bib110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2019.05.002","article-title":"Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir","volume":"168","author":"Georgel","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.micpath.2026.108823_bib111","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108823_bib112","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4049\/jimmunol.167.4.1882","article-title":"Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression","volume":"167","author":"Gewirtz","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib113","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.4049\/jimmunol.170.10.5165","article-title":"The toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells","volume":"170","author":"Means","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib114","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/IAI.66.3.1127-1134.1998","article-title":"Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line","volume":"66","author":"Ciacci-Woolwine","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib115","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1128\/IAI.67.7.3619-3624.1999","article-title":"Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes","volume":"67","author":"Wyant","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib116","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molimm.2010.07.006","article-title":"Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC","volume":"48","author":"Sch\u00fclke","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI10501","article-title":"Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response","volume":"107","author":"Gewirtz","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2026.108823_bib118","doi-asserted-by":"crossref","first-page":"13346","DOI":"10.1074\/jbc.M200149200","article-title":"The Salmonella typhimurium flagellar basal body protein FliE is required for flagellin production and to induce a proinflammatory response in epithelial cells","volume":"277","author":"Reed","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108823_bib119","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14760584.2018.1457443","article-title":"Flagellin as a vaccine adjuvant","volume":"17","author":"Cui","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2026.108823_bib120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.52547\/vacres.8.2.17","article-title":"Roles and functions of toll-like receptors in coronavirus infections: forthcoming vaccine and therapeutic strategies for confronting COVID","volume":"8","author":"Zahmatkesh","year":"2021","journal-title":"Vaccine Res."},{"key":"10.1016\/j.micpath.2026.108823_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2021.101622","article-title":"Comparison of flagellin and an oil-emulsion adjuvant in inactivated Newcastle disease vaccine in stimulation of immunogenic parameters","volume":"75","author":"Barkhordari","year":"2021","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2022.101796","article-title":"Evaluation of cellular and humoral immune response in chickens immunized with flagellin-adjuvanted inactivated newcastle disease virus","volume":"85","author":"Bagheri","year":"2022","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib123","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1158\/0008-5472.CAN-14-2467","article-title":"TLR5 ligand-secreting T cells reshape the tumor microenvironment and enhance antitumor activity","volume":"75","author":"Geng","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.micpath.2026.108823_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187212","article-title":"Clostridium difficile flagellin FliC: evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile","volume":"12","author":"Bruxelle","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108823_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.108124","article-title":"Protection efficacy and immunogenicity of Clostridium chauvoei proteins as a subunit blackleg vaccine or an adjuvant for Clostridium perfringens epsilon toxoid","volume":"251","author":"Hamzavipour","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.micpath.2026.108823_bib126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-1759(91)90298-T","article-title":"Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens","volume":"142","author":"Hormaeche","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.micpath.2026.108823_bib127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/08830189409061724","article-title":"Immune responses to epitopes inserted in Salmonella flagellin","volume":"11","author":"Stocker","year":"1994","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib128","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cmi.2011.24","article-title":"Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib129","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative safety of vaccine adjuvants: a summary of current evidence and future needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.micpath.2026.108823_bib130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib131","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2026.108823_bib132","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib133","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1016\/j.vaccine.2018.04.066","article-title":"The influence of the intestinal microbiome on vaccine responses","volume":"36","author":"Zimmermann","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib134","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vaccine.2017.08.069","article-title":"The influence of probiotics on vaccine responses \u2013 a systematic review","volume":"36","author":"Zimmermann","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib136","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1007\/s00253-019-09770-7","article-title":"Targeting ideal oral vaccine vectors based on probiotics: a systematical view","volume":"103","author":"Jiang","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108823_bib137","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/vaccines7040150","article-title":"Adjuvant strategies for lactic acid bacterial mucosal vaccines","volume":"7","author":"Vilander","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2026.108823_bib138","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/08820130903563998","article-title":"Heat-labile enterotoxins as adjuvants or anti-inflammatory agents","volume":"39","author":"Liang","year":"2010","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.micpath.2026.108823_bib139","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.vaccine.2010.02.077","article-title":"Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface","volume":"28","author":"Kajikawa","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib140","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/CVI.00049-12","article-title":"Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery","volume":"19","author":"Kajikawa","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8020297","article-title":"Safety aspects of genetically modified lactic acid bacteria","volume":"8","author":"Plavec","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108823_bib142","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jam.13446","article-title":"Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts","volume":"123","author":"Szatraj","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib143","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1128\/jb.172.7.4109-4114.1990","article-title":"Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E","volume":"172","author":"Witte","year":"1990","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108823_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144397","article-title":"Bacterial ghosts of Escherichia coli drive efficient maturation of bovine monocyte-derived dendritic cells","volume":"10","author":"Hajam","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108823_bib145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-3659(99)00099-1","article-title":"Bacterial ghosts as drug carrier and targeting vehicles","volume":"61","author":"Huter","year":"1999","journal-title":"J Control Release"},{"key":"10.1016\/j.micpath.2026.108823_bib146","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.addr.2005.01.027","article-title":"Bacterial ghosts as antigen delivery vehicles","volume":"57","author":"Mayr","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2026.108823_bib147","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-017-0442-5","article-title":"Bacterial ghosts as adjuvants: mechanisms and potential","volume":"48","author":"Hajam","year":"2017","journal-title":"Vet Res"},{"key":"10.1016\/j.micpath.2026.108823_bib148","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2014.08.072","article-title":"Comparative evaluation of Salmonella Enteritidis ghost vaccines with a commercial vaccine for protection against internal egg contamination with Salmonella","volume":"32","author":"Jawale","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/srep17479","article-title":"Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7","volume":"5","author":"Cai","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108823_bib150","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/eji.200939913","article-title":"Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway","volume":"40","author":"Adam","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib151","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1189\/jlb.1009674","article-title":"Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari","volume":"88","author":"Quevedo-Diaz","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2026.108823_bib152","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/BC.2008.054","article-title":"Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors","volume":"389","author":"Benko","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108823_bib153","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/ijms11030789","article-title":"Interleukin 12 a key immunoregulatory cytokine in infection applications","volume":"11","author":"Hamza","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib154","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.4049\/jimmunol.172.11.6858","article-title":"Bacterial ghosts are an efficient delivery system for DNA vaccines","volume":"172","author":"Ebensen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib155","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.22.012703.104538","article-title":"Cell biology of antigen processing in vitro and in vivo","volume":"23","author":"Trombetta","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib156","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fmicb.2017.01053","article-title":"Outer Membrane Vesicles (OMVs) of Gram-negative bacteria: a perspective update","volume":"8","author":"Jan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2022.0145","article-title":"Gram-negative bacteria's outer membrane vesicles","volume":"55","author":"Kim","year":"2023","journal-title":"Infect Chemother"},{"key":"10.1016\/j.micpath.2026.108823_bib158","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1490732","article-title":"Outer membrane vesicles (OMVs) produced by gram-negative bacteria: structure, functions, biogenesis, and vaccine application","volume":"2021","author":"Furuyama","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.micpath.2026.108823_bib159","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/bj0960567","article-title":"An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions","volume":"96","author":"Bishop","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.micpath.2026.108823_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/00221287-49-1-1","article-title":"Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae","volume":"49","author":"Chatterjee","year":"1967","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib161","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0022-2836(69)90374-X","article-title":"Synthesis and assembly of bacterial membrane components. A lipopolysaccharide-phospholipid-protein complex excreted by living bacteria","volume":"44","author":"Rothfield","year":"1969","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108823_bib162","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/vaccines13070767","article-title":"Bioengineering outer-membrane vesicles for vaccine development: strategies, advances, and perspectives","volume":"13","author":"Zahid","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2026.108823_bib163","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12934-025-02653-9","article-title":"Review on bacterial outer membrane vesicles: structure, vesicle formation, separation and biotechnological applications","volume":"24","author":"Zhao","year":"2025","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.micpath.2026.108823_bib164","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics13020131","article-title":"Bacterial-derived outer membrane vesicles are potent adjuvants that drive humoral and cellular immune responses","volume":"13","author":"Prior","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108823_bib165","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/life14121584","article-title":"Immune responses elicited by outer membrane vesicles of Gram-negative bacteria: important players in vaccine development","volume":"14","author":"Velimirov","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.micpath.2026.108823_bib166","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biology13070485","article-title":"The impact of VP-porin, an outer membrane protein, on the biological characteristics and virulence of Vibrio parahaemolyticus","volume":"13","author":"Che","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.micpath.2026.108823_bib167","article-title":"Proteomic and bioinformatic analyses of proteins in the outer membrane and extracellular compartments and outer membrane vesicles of Candidatus Liberibacter species","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.136685","article-title":"Proteomic characterization of extracellular vesicles derived from lactic acid bacteria","volume":"427","author":"Lee","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.micpath.2026.108823_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.70086","article-title":"Outer membrane vesicles from Bacteroides fragilis contain coding and non-coding small RNA species that modulate inflammatory signalling in intestinal epithelial cells","volume":"4","author":"Sheikh","year":"2025","journal-title":"J Extracell Biol"},{"key":"10.1016\/j.micpath.2026.108823_bib170","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijmm.2018.06.001","article-title":"Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes","volume":"308","author":"Liu","year":"2018","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib171","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00968-21","article-title":"Outer membrane vesicles derived from Salmonella enterica serotype typhimurium can deliver Shigella flexneri 2a O-polysaccharide antigen to prevent Shigella flexneri 2a infection in mice","volume":"87","author":"Tian","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib172","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00313-23","article-title":"Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice","volume":"91","author":"Liu","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib173","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2367783","article-title":"Outer membrane vesicles from genetically engineered Salmonella enterica serovar Typhimurium presenting Helicobacter pylori antigens UreB and CagA induce protection against Helicobacter pylori infection in mice","volume":"15","author":"Liu","year":"2024","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2026.108823_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70085","article-title":"Development of a recombinant outer membrane vesicles (OMVs)-based vaccine against Helicobacter pylori infection in mice","volume":"14","author":"Liu","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.micpath.2026.108823_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2019.151356","article-title":"sncRNAs packaged by Helicobacter pylori outer membrane vesicles attenuate IL-8 secretion in human cells","volume":"310","author":"Zhang","year":"2020","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib176","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00267-22","article-title":"Disruption of sncRNA improves the protective efficacy of outer membrane vesicles against Helicobacter pylori infection in a mouse model","volume":"90","author":"Li","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108823_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1193198","article-title":"Bacterial growth stage determines the yields, protein composition, and periodontal pathogenicity of Porphyromonas gingivalis outer membrane vesicles","volume":"13","author":"Mao","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib178","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01707-21","article-title":"Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance","volume":"12","author":"Zhu","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108823_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124416","article-title":"OMV vaccines and the role of TLR agonists in immune response","volume":"21","author":"Mancini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108823_bib181","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/ijms22031005","article-title":"Detection of bacterial membrane vesicles by NOD-like receptors","volume":"22","author":"Johnston","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib182","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.actbio.2019.04.033","article-title":"Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells","volume":"91","author":"Schetters","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.micpath.2026.108823_bib183","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41551-022-00886-2","article-title":"Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria","volume":"6","author":"Yue","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.micpath.2026.108823_bib184","article-title":"Inhalable engineered probiotic outer membrane vesicles co-expressing multiple mpox antigens induce potent specific systemic and mucosal immune responses","volume":"38","author":"Fu","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.micpath.2026.108823_bib185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.vaccine.2005.07.064","article-title":"Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant","volume":"24","author":"Sardi\u00f1as","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib186","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1007\/s00253-019-10163-z","article-title":"Continuous production of Neisseria meningitidis outer membrane vesicles","volume":"103","author":"Gerritzen","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108823_bib187","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40259-023-00627-0","article-title":"Outer membrane vesicle vaccine platforms","volume":"38","author":"Micoli","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.micpath.2026.108823_bib188","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bit.27965","article-title":"Outer membrane vesicles (OMVs) enabled bio-applications: a critical review","volume":"119","author":"Huang","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.micpath.2026.108823_bib189","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41541-025-01190-1","article-title":"A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice","volume":"10","author":"Spinsanti","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.micpath.2026.108823_bib190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14760584.2022.2009803","article-title":"GMMA as a \u201cplug and play\u201d technology to tackle infectious disease to improve global health: context and perspectives for the future","volume":"21","author":"Piccioli","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2026.108823_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70274","article-title":"An engineered nano-vesicle adjuvant platform (ENAP) for cytokine delivery enables a novel antigen-coordinated vaccine against Helicobacter pylori","volume":"15","author":"Shang","year":"2026","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.micpath.2026.108823_bib192","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: an update","volume":"323","author":"Li","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.micpath.2026.108823_bib193","article-title":"A hybrid eukaryotic-prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination","volume":"32","author":"Chen","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.micpath.2026.108823_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101007","article-title":"Nanovaccines integrating endogenous antigens and pathogenic adjuvants elicit potent antitumor immunity","volume":"35","author":"Li","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.micpath.2026.108823_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121810","article-title":"A heterogenic membrane-based biomimetic hybrid nanoplatform for combining radiotherapy and immunotherapy against breast cancer","volume":"289","author":"Pan","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.micpath.2026.108823_bib196","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001666","article-title":"Thylakoid membranes with unique photosystems used to simultaneously produce self-supplying oxygen and singlet oxygen for hypoxic tumor therapy","volume":"10","author":"Cheng","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.micpath.2026.108823_bib197","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","article-title":"Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108823_bib198","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1021\/acs.nanolett.2c01280","article-title":"Phytochemical engineered bacterial outer membrane vesicles for photodynamic effects promoted immunotherapy","volume":"22","author":"Zhuang","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.micpath.2026.108823_bib199","article-title":"Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy","volume":"23","author":"Tong","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.micpath.2026.108823_bib200","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.912639","article-title":"Outer Membrane Vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells","volume":"12","author":"Tomasi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.micpath.2026.108823_bib201","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.bsheal.2026.07.004","article-title":"Evolving priorities in the WHO bacterial priority pathogens list","author":"Ouyang","year":"2026","journal-title":"Biosaf Health"},{"key":"10.1016\/j.micpath.2026.108823_bib203","article-title":"Immunogenicity evaluation of altSonflex1-2-3 Shigella vaccine across mice, rats, and rabbits to inform human translational insights","volume":"16","author":"Caradonna","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib204","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1652460","article-title":"Antibodies elicited by altSonflex1-2-3 GMMA vaccine are bactericidal against a panel of drug-resistant Shigella clinical isolates","volume":"16","author":"Boero","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib205","article-title":"Protection against N. gonorrhoeae induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41541-024-01018-4","article-title":"NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae","volume":"9","author":"Tzeng","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.micpath.2026.108823_bib207","article-title":"Identification and evaluation of recombinant outer membrane proteins as vaccine candidates against Klebsiella pneumoniae","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.70351","article-title":"Engineered bacterial membranes as next-generation platforms for cancer immunotherapy","volume":"6","author":"Malik","year":"2026","journal-title":"Small Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib209","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70350","article-title":"Bacterial Extracellular Vesicles in biomedical research and clinical translation","volume":"19","author":"Arce-Rodr\u00edguez","year":"2026","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108823_bib210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12951-024-02935-1","article-title":"Opportunities and challenges of bacterial extracellular vesicles in regenerative medicine","volume":"23","author":"Guo","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.micpath.2026.108823_bib211","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.vaccine.2003.08.027","article-title":"Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines","volume":"22","author":"Arigita","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108823_bib212","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/d41591-023-00069-9","article-title":"GSK's gonorrhea vaccine receives fast-track designation to expedite clinical trials","volume":"29","author":"Johnson","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.micpath.2026.108823_bib213","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3389\/fimmu.2017.01884","article-title":"A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered intramuscularly to adults from a shigellosis-endemic country","volume":"8","author":"Obiero","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108823_bib214","doi-asserted-by":"crossref","first-page":"e971","DOI":"10.1093\/infdis\/jiae273","article-title":"Safety and immunogenicity of a 4-component generalized modules for membrane antigens Shigella vaccine in healthy European adults: randomized, phase 1\/2 study","volume":"230","author":"Leroux-Roels","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108823_bib215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072938","article-title":"Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort","volume":"13","author":"Hanumunthadu","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.micpath.2026.108823_bib216","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/14760584.2023.2270596","article-title":"The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development","volume":"22","author":"Skidmore","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2026.108823_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110295","article-title":"Flagellin as a versatile adjuvant platform: genetic fusion approaches for next-generation vaccines","volume":"26","author":"Mardanova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108823_bib218","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/pharmaceutics13111892","article-title":"Bacterial ghosts-based vaccine and drug delivery systems","volume":"13","author":"Chen","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:19:39Z","timestamp":1789831179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":218,"alternative-id":["S0882401026005498"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108823","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing bacterial biology and components for next-generation vaccine development","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108823"}}